oncology center
Entity, reached from Hormuz.
- Evidence
- 25 documents · 7 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 25 Jun 2026, last seen 9 Oct 2026
- Measured
- 76% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- FDA D.I.S.C.O. (Drug Info Soundcast in Clinical · 2026-09-18 · Project Orbis (opens the source in a new tab)
- Fierce Biotech · 2026-09-10 · In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy (opens the source in a new tab)
- Fierce Pharma · 2026-09-04 · FDA files reveal lingering concerns, contrasting views behind Replimune melanoma nod (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with fda (24 documents)seen together
- co-mentioned with drug administration (14 documents)seen together
- co-mentioned with clinical trial (11 documents)seen together
- co-mentioned with clinical trials (10 documents)seen together
- co-mentioned with inds (9 documents)seen together
- co-mentioned with public health (9 documents)seen together
- co-mentioned with priority review (8 documents)seen together
- co-mentioned with adverse events (8 documents)seen together
- co-mentioned with her2 (8 documents)seen together